GENFIT Stock Deutsche Boerse AG
Stocks
XUP
FR0004163111
Biotechnology & Medical Research
OTC Markets Traded|
Real-time Estimate
Tradegate
15:04:34 2026-08-20 EDT
|
5-day change | 1st Jan Change | ||
| 14.09 EUR | +3.30% |
|
+10.46% | +173.78% |
| 07-03 | Genfit soars on news of U.S. reimbursement for a product |  |
| 07-03 | Genfit's Liver Disease Blood Test Approved for US Medicare Reimbursement | MT |
| Market Cap | 705M 824M 658M 604M 1.13B 78.83B 1.16B 7.81B 3.04B 39.5B 3.09B 3.03B 131B | P/E 2026 * |
37.2x | P/E 2027 * | 95.6x |
|---|---|---|---|---|---|
| Enterprise Value | 654M 764M 610M 560M 1.05B 73.11B 1.07B 7.24B 2.82B 36.64B 2.87B 2.81B 121B | EV / Sales 2026 * |
6.53x | EV / Sales 2027 * | 5.15x |
| Free-Float |
86.89% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +3.30% | ||
| 1 week | +10.46% | ||
| Current month | +2.43% | ||
| 1 month | +12.72% | ||
| 3 months | +71.57% | ||
| 6 months | +76.52% | ||
| Current year | +173.78% |
| 1 week | 12.94 |  | 14.36 |
| 1 month | 12.72 | | 14.86 |
| Current year | 5.08 | | 14.86 |
| 1 year | 3.01 | | 14.86 |
| 3 years | 2.8 | | 14.86 |
| 5 years | 2.74 | | 14.86 |
| 10 years | 2.74 | | 33.76 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Prigent
CEO | Chief Executive Officer | 58 | 2019-09-15 |
Thomas Baetz
DFI | Director of Finance/CFO | 52 | 2021-04-21 |
Pejvack Motlagh
CTO | Chief Tech/Sci/R&D Officer | - | 2025-11-26 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | 2017-06-15 | |
| Director/Board Member | 54 | 1999-09-14 | |
| Director/Board Member | 58 | 2017-06-15 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.30% | +10.46% | - | - | 840M | |
| +1.14% | +2.27% | +2.38% | +24.66% | 50.5B | |
| -1.61% | +4.48% | +483.63% | +606.53% | 46.01B | |
| -1.15% | +4.56% | +20.33% | +89.80% | 42.85B | |
| +3.88% | +7.44% | +35.12% | +21.05% | 41.03B | |
| 0.00% | -3.91% | +17.87% | +47.98% | 32.02B | |
| +1.04% | +6.33% | +32.87% | +151.56% | 16.98B | |
| -1.28% | +3.85% | - | - | 17.05B | |
| +3.06% | +3.88% | +5.81% | +35.45% | 14.3B | |
| +2.19% | +5.94% | +86.72% | +48.31% | 13.84B | |
| Average | +1.08% | +2.01% | +85.59% | +128.17% | 30.51B | |
| Weighted average by Cap. | +0.65% | +2.37% | +105.22% | +152.01% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 100M 117M 93.49M 85.78M 161M 11.2B 164M 1.11B 432M 5.61B 439M 430M 18.58B | 124M 145M 116M 106M 200M 13.86B 203M 1.37B 535M 6.95B 544M 532M 23B |
| Net income | 22.88M 26.72M 21.35M 19.59M 36.8M 2.56B 37.53M 253M 98.71M 1.28B 100M 98.15M 4.24B | 6.8M 7.94M 6.34M 5.82M 10.94M 760M 11.15M 75.27M 29.34M 381M 29.82M 29.17M 1.26B |
| Net Debt | -51.12M -59.7M -47.69M -43.76M -82.23M -5.71B -83.85M -566M -221M -2.86B -224M -219M -9.48B | -66.17M -77.29M -61.74M -56.65M -106M -7.4B -109M -732M -286M -3.71B -290M -284M -12.27B |
| Date | Price | Change |
|---|---|---|
| 26-08-20 | €14.36 | +5.28% |
| 26-08-19 | €13.64 | -0.73% |
| 26-08-18 | €13.74 | +6.18% |
| 26-08-17 | €12.94 | -2.85% |
| 26-08-14 | €13.32 | +2.46% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GNFT Stock
- XUP Stock
Select your edition
All financial news and data tailored to specific country editions
